Group SFA-after intervention. by Nan Tang (642590)

Subjects:

Intervention process of two groups. by Nan Tang (642590)

Subjects:

Effect of different doses (mg/Kg) of the defatted extract (DE) of the leaves of <i>S. malaccense</i> and <i>S. samarangense</i> on serum ALT and AST levels. Data represented as mea... by Fatma A. Moharram (9276104)

Subjects:

NMN increases SIRT3 expression at both mRNA and protein levels in the brain 6 h after cardiac arrest. by Daiki Kaito (12514087)

Alterations in hematological parameters induced by dimethoate after 90 days. by Nida Saleem (17194610)

Subjects:

Alterations in hematological parameters induced by dimethoate after 30 days. by Nida Saleem (17194610)

Subjects:

IGF-1 increases mature collagen in females in mice with systemic MMP8 deficiency and myeloid MMP8 reintroduction. by Patricia Snarski (22305205)

Quantification of bacterial adhesion revealed a significant decrease in the adhesion of <i>S. aureus</i>, <i>S. epidermidis</i>, and <i>P. aeruginosa</i> on blotted corneas of mice... by Ananya Datta (19932144)

Variable settings and assignment descriptions. by Yuling Jin (11872953)

“…Binary logit regression models were employed to analyze the driving mechanism of the current farmland abandonment based on 1,195 questionnaires, and then random forest models were used to predict future farmland abandonment trends under various scenarios. The results showed that (1) rural population aging had emerged as a significant challenge for Ulanqab, with the proportion of people aged 60 and above increasing from 12.3% in 2000 to 44.9% in 2020. …”

Socio-demographic and medical characteristics of patients with liver cancer. by Ayana Ablayeva (22103708)

Subjects:

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

Subjects:

Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). by Ayana Ablayeva (22103708)

Subjects:

Regional differences in percentage changes of N07BA drug prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects: